OBSOLETE: Common variable immunodeficiency Advocacy Hub | UniteRare

Regulatory Watchboard

No FDA or trial events recorded yet for OBSOLETE: Common variable immunodeficiency.

Financial Assistance

FINANCIAL LANDSCAPE SUMMARY

Total programs

No financial assistance programs currently listed for OBSOLETE: Common variable immunodeficiency.
Check the disease page for updates →

Approved Treatments

1 FDA-approved

Gamimune N

(Immune globulin intravenous, human)Orphan drugstandard

Bayer Corporation

Human Immunoglobulin G [EPC]

12.1 Mechanism of Action BIVIGAM is a replacement therapy in patients with primary humoral immunodeficiency (PI) (e.g. agammaglobulinaemia, hypogammag...

FDA label ↗

View full treatment details on disease page →

Clinical Trial Landscape

No active clinical trials currently recruiting for OBSOLETE: Common variable immunodeficiency.
Search all trials →

Search clinical trials for OBSOLETE: Common variable immunodeficiency →

Recent News & Research

No recent news articles indexed yet for OBSOLETE: Common variable immunodeficiency.
Search PubMed for OBSOLETE: Common variable immunodeficiency →

Browse all OBSOLETE: Common variable immunodeficiency news →

Specialist Network

No specialists currently listed for OBSOLETE: Common variable immunodeficiency.

View all OBSOLETE: Common variable immunodeficiency specialists →

Quick Actions

📄

View Disease Page

Full profile, treatments, community

🔬

Search Clinical Trials

Find recruiting studies now

🩺

Find Specialists

Ranked by expertise & trials

💰

Financial Assistance

Copay cards, PAPs, grants

📰